301263.SZ · 泰恩康
China A-shares · RS rating 11 · As of 2026-10-14
| Price | 18.38 CNY |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 37 / 32 / 8 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 14 / 10 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -31.0% |
| Distance from 52-week high | +46.6% |
| Market cap (USD) | $1.5B |